April 1, 2015 / 6:28 AM / 2 years ago

BRIEF-Stellar Biotechnologies and Neovacs expand KLH supply relationship

1 Min Read

April 1 (Reuters) - Neovacs SA :

* Says expands KLH supply relationship with Stellar Biotechnologies

* Companies sign KLH supply agreement for Neovacs' kinoid clinical trials and initial commercialization

* Companies have entered into an expanded supply agreement to meet Neovacs' requirements for keyhole limpet hemocyanin (KLH) Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below